Trial Profile
Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Cyclophosphamide; Cytarabine; Cytarabine; Dexamethasone; Dexamethasone; Mercaptopurine; Methotrexate; Mitoxantrone; Pegaspargase; Vincristine
- Indications Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 22 Jun 2016 Status changed from recruiting to discontinued.
- 28 Jun 2013 Planned End Date changed from 1 Mar 2017 to 1 Apr 2017 as reported by ClinicalTrials.gov.
- 15 Nov 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.